ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Approach to Managing a Postmenopausal Patient
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 190123" data-attributes="member: 13851"><p><strong>Figure 2: <span style="color: rgb(184, 49, 47)">Absolute and relative contraindications to the use of estrogens as contained in MHT.</span> <span style="color: rgb(44, 130, 201)">Data were taken from the Endocrine Society Guidelines on Menopausal Hormone therapy 7. </span><span style="color: rgb(26, 188, 156)">In general, MHT should not be used in women with conditions listed under absolute contraindications. Caution should also be exercised in women with relative contraindications. Advice not to use estrogens in the specific conditions listed is based on FDA recommendations and package labeling in the United States. The advice to exercise caution is based on a review of the literature and not dictums generally described in various menopause society guidelines. Because these contraindications are meant to be used internationally, it should be noted that these considerations may vary from country to country. </span><span style="color: rgb(184, 49, 47)">As transdermal estrogen is safer than oral for several conditions such as hypertriglyceridemia and migraine with aura, the route of administration is an important consideration.</span> <span style="color: rgb(44, 130, 201)">From Stuenkel CA et al 7</span></strong></p><p>[ATTACH=full]11447[/ATTACH]</p></blockquote><p></p>
[QUOTE="madman, post: 190123, member: 13851"] [B]Figure 2: [COLOR=rgb(184, 49, 47)]Absolute and relative contraindications to the use of estrogens as contained in MHT.[/COLOR] [COLOR=rgb(44, 130, 201)]Data were taken from the Endocrine Society Guidelines on Menopausal Hormone therapy 7. [/COLOR][COLOR=rgb(26, 188, 156)]In general, MHT should not be used in women with conditions listed under absolute contraindications. Caution should also be exercised in women with relative contraindications. Advice not to use estrogens in the specific conditions listed is based on FDA recommendations and package labeling in the United States. The advice to exercise caution is based on a review of the literature and not dictums generally described in various menopause society guidelines. Because these contraindications are meant to be used internationally, it should be noted that these considerations may vary from country to country. [/COLOR][COLOR=rgb(184, 49, 47)]As transdermal estrogen is safer than oral for several conditions such as hypertriglyceridemia and migraine with aura, the route of administration is an important consideration.[/COLOR] [COLOR=rgb(44, 130, 201)]From Stuenkel CA et al 7[/COLOR][/B] [ATTACH type="full"]11447[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Approach to Managing a Postmenopausal Patient
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top